Article
Oral lichen planus and HCV infection: a clinical evaluation of 263 cases.
Department of Oral Medicine and Pathology, University of Naples Federico II, Faculty of Medicine, School of Dentistry, Italy.
International Journal of Dermatology (impact factor:
1.14).
09/1998;
37(8):575-8.
pp.575-8
Source: PubMed
-
Citations (0)
- Cited In (10)
-
Article: Association between hepatitis C virus infection and oral lichen planus in Israeli patients.
[show abstract] [hide abstract]
ABSTRACT: Oral lichen planus is a cell-mediated immune condition of unknown etiology. A possible association of OLP with hepatitis C virus infection has been documented in specific populations. However, no such possible association has been studied in Israel. To assess the prevalence of HCV antibodies among patients with OLP in Israel. The prevalence of HCV seropositivity was studied in OLP patients (n=62) and compared with that of a control group (n=65) and with the prevalence among healthy volunteer blood donors (n=225,452) as representatives of the general population. The prevalence of HCV, as detected by the presence of anti-HCV antibodies screened by enzyme-linked immunosorbent assay, and confirmed by recombinant immunoblot assay, was 4.8%, 1.5% and 0.1%, respectively. HCV seropositivity in the OLP patients was significantly higher than in the healthy blood donors (P< 0.001). A possible association between OLP and HCV is suggested. Therefore, screening OLP patients for antibodies to HCV is recommended.The Israel Medical Association journal: IMAJ 05/2007; 9(5):370-2. · 1.02 Impact Factor -
Article: Oral lichen planus and chronic hepatitis C: a controversial association.
[show abstract] [hide abstract]
ABSTRACT: Our aim was to study the possible association between oral lichen planus and chronic hepatitis C in patients from the state of Minas Gerais, Brazil. Two groups of patients were studied: group 1, 50 patients with oral lichen planus evaluated for the presence of chronic hepatitis C; and group 2, 215 patients with chronic hepatitis C examined for evidence of oral lichen planus. Diagnosis of oral lichen planus in both groups was based on clinical and histologic findings. One case of chronic hepatitis C was diagnosed in group 1 (2.0%), which was not considered statistically significant (P = .464). In group 2, the prevalence of oral lichen planus was 2.3% (5 cases), which showed statistical significance (P = .002). Although our results suggest oral lichen planus as an extrahepatic manifestation of chronic hepatitis C in the studied population, the association between these two entities should be further investigated.American Journal of Clinical Pathology 06/2007; 127(5):800-4. · 2.60 Impact Factor -
Article: Prevalence of oral lichen planus in Brazilian patients with HCV infection.
[show abstract] [hide abstract]
ABSTRACT: The objective of this investigation was to assess the prevalence of oral lichen planus (OLP) in Brazilian patients infected with hepatitis C virus (HCV) from the state of Rio de Janeiro. The study group consisted of 134 patients with HCV infection. The control group consisted of 95 individuals. All patients were physically examined for evidence of OLP. The diagnosis of OLP was established on the basis of usual clinical features and histological findings. The prevalence of OLP was 1.5% in patients with HCV infection and 1.1% in the control group. There was no statistically significant difference between the 2 groups (P = .63). Our findings indicate that there is no association between OLP and HCV infection in Brazilian patients from the state of Rio de Janeiro.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 10/2005; 100(3):330-3. · 1.50 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
31 patients
43 patients
control group
control population
ELISA II
Federico II
findings stress
HCV antibodies
HCV antibody positivity
HCV infection
healthy population
hepatitis B virus
Hepatitis C virus
hepatitis D virus
mean age
OLP patients
RIBA II
second-generation recombinant immunoblot assay
serum transaminase
two diseases